In 2023, the German antiinfective medicine market stood at approximately $3.22 billion. Forecasts from 2024 to 2028 show a steady growth trajectory, with sales expected to reach $3.51 billion by 2028. Year-on-year growth is modest yet consistent, averaging about 1.4% per year, reflecting stable demand in the market.
Key future trends to watch for include:
- Emerging resistance to current antiinfective treatments, requiring innovation and new product developments.
- Increased healthcare spending and aging population potentially driving demand.
- The impact of regulatory changes and global health initiatives on market dynamics.
- Advancements in biotechnology that may introduce novel antiinfective treatments.
